CrystaLens Accomodating Lens
The Crystalens® is an accommodating intraocular lens that, unlike a standard IOL, can treat both a person’s cataracts and presbyopia- loss of near and intermediate vision. You probably noticed in your forties that you started to lose some of your up-close vision and had to start wearing reading glasses. Crystalens not only treats your cataracts (a clouding or hardening of your lens), but can also reduce or eliminate your dependence on glasses. It does so by recreating accommodation similar to your eye’s natural lens. The unique Crystalens can reduce or eliminate glasses for most activities including: reading a book, working on the computer, and driving a car.
The Crystalens was modeled after the human eye. Like the natural lens, it uses the eye muscle to flex and accommodate in order to focus on objects in the environment at all distances. Crystalens dynamically adjusts to your visual needs. In the aging eye the lens loses its ability to change shape and images are out of focus. Reading glasses or bifocals are required to help the eye focus. This condition, which begins to affect most people in their forties, is called presbyopia. Presbyopia is the inability of your eyes to accommodate.
The Crystalens is designed to allow the optic, or the central circular part of the lens that you see through, to move back and forth as you constantly change focus on images around you. Crystalens flexes as you focus your vision.
- The first and only FDA-approved accommodating intraocular lens
- The only FDA approved intraocular lens that uses the natural focusing ability of the eye
- The only FDA approved presbyopia correcting IOL for cataract patients that provides a single focal point throughout a continuous range of vision
Few patients with Crystalens have experienced problems with glare, halos and night vision. crystalens focuses only one image to the back of the eye, unlike a multifocal lens that projects multiple images, requiring your brain to “adjust” to the differences.
The effectiveness of Crystalens® was proven in clinical trials:
- Significantly more patients implanted with a Crystalens (88.4%) could see better at all distances then patients
implanted with a standard IOL (35.9%).
- Most patients have continued to report excellent vision 7 years after implantation with Crystalens. More than
95,000 crystalens implants have been implanted worldwide, and that number is growing daily.
Crystalens accommodates like the natural lens. After implantation of Crystalens, most patients will see brighter and clearer from distance, intermediate to near like they did when they were younger.
In clinical trials, more than 98% of patients who received Crystalens implants in both eyes had uncorrected visual acuity of 20/30 or better at distance without glasses, and could read 6 point type on a medicine bottle; and 92% had distance visual acuity of 20/25 or better. All enjoyed good intermediate vision one year after implantation, and 93.8% of patients surveyed said they could perform most daily activities without glasses.
ONLY FDA-Approved accommodating IOL
The Crystalens was the first presbyopia correcting IOL introduced into the United States market and is currently the only FDA-approved accommodating IOL. Crystalens addresses the limitations of standard monofocal IOLs and multifocal IOLs by providing the following advantages to patients:
Provides a Broad Range of Vision: Crystalens moves and changes shape using the eye's
natural focusing mechanism, instead of remaining fixed and stationary within the eye. This
movement, or accommodation, allows the eye to focus on objects across a broad range of
distances to reduce or eliminate dependence on glasses. In particular, this accommodation
provides significant advantages in addressing intermediate vision.
- Maintains Clarity of Vision: Unlike multifocal lenses, Crystalens directs all available light
received by the eye to a single focal point, comparable to that of a healthy natural lens.
- Patient Adjustment Not Required: Crystalens produces a single image consistent with normal vision,
meaning patients do not need to neuroadapt to viewing multiple images. Patients also do not need to
tolerate or adjust to high levels of halos and glare often associated with multifocal IOLs.
The actual Crystalens is implanted utilizing a traditional small-incision cataract surgery procedure. Dr John Baldinger uses the “no needles, no stitch, no patch” surgery technique, so you are relaxed and comfortable throughout the procedure. It takes only about ten minutes and is performed as an outpatient procedure.
Dr. Baldinger, was the first eye surgeon in the Northern Virginia to incorporate this technology into their practice. Performing over 1400 cataract procedures a year, Dr. Baldinger is one of the busiest cataract surgeon in the Washington DC area. For more information on Crystalens go to.. http://www.crystalens.com/us/